This is a $8,153.96 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Restasis 0.05% eye emulsion. The contract has an ultimate completion date of July 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Restasis 0.05% eye emulsion, a specialty medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,406.73 and a completion date of November 1, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,308.31, is for the delivery of Restasis 0.05% eye emulsion. The contract has an ultimate completion date of November 22, 2023 and was awarded on November 21, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not...
This is a delivery order under a prime contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,788.03, is for the delivery of Restasis 0.05% eye emulsion product. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,829.36 contract is for the supply of Restasis 0.05% eye emulsion, a branded ophthalmic medication. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,397.25, is for the supply of Restasis 0.05% eye emulsion. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Restasis 0.05% eye emulsion. The contract has a ceiling value of $2,720.69 and runs through July 18, 2022. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,443.18 firm fixed-price contract is for the supply of Restasis 0.05% eye emulsion, a specialty ophthalmic medication. The contract has a completion date of February 19, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $11,092.19, is for the supply of Restasis 0.05% eye emulsion, a prescription ophthalmic medication. The contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,837.22, is for the supply of Restasis 0.05% Eye Emulsion 30S, a prescription eye medication. The contract has a completion date of July 18, 2022 and is a Firm Fixed Price agreement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...